How to differentiate benign from malignant myometrial tumours using MR imaging

Area of Science:

• Radiology
• Oncology
• Women's Health

Background:

• Myometrial tumors require accurate differentiation between benign and malignant types.
• Magnetic resonance imaging (MRI) is a key modality for evaluating uterine masses.

Purpose of the Study:

• To assess the efficacy of MRI in distinguishing malignant from benign myometrial tumors.
• To develop a diagnostic model for myometrial tumor characterization using MRI.

Main Methods:

• Retrospective analysis of 51 women with solitary myometrial tumors who underwent pre-operative MRI.
• Evaluation of conventional MRI criteria, b 1,000 signal intensity, and apparent diffusion coefficient (ADC).
• Multivariate analysis to construct a predictive interpretation model.

Main Results:

• High b 1,000 signal intensity, intermediate T2-weighted signal, and lower mean ADC were significant predictors of malignancy.
• Patient age, intra-tumoral hemorrhage, endometrial thickening, and T2 signal heterogeneity also indicated malignancy.
• The developed model, incorporating T2 signal, b 1,000 signal, ADC, and patient age, achieved 92.4% accuracy in classifying tumors.

Conclusions:

• An MRI-based interpretation model combining T2 signal, b 1,000 signal, and ADC measurements is effective for routine clinical practice.
• Diffusion-weighted imaging (DWI) can help prevent misdiagnosis of uterine sarcoma as leiomyoma.
• Patient age is a crucial factor in the assessment of solitary myometrial tumors.